CYTOKINETICS, INCORPORATED Total Liabilities
CYTOKINETICS, INCORPORATED (CYTK) had Total Liabilities of $2.10 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $2.10B.
- 2026-03-31: Liabilities $2.10B.
- 2025-12-31: Liabilities $2.08B.
- 2025-09-30: Liabilities $1.96B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $2.10B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $2.10B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $2.08B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.96B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.59B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.53B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.54B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.45B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.42B 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $1.20B 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.21B 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.18B 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $1.11B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.12B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $1.12B 10-K · filed 2024-02-28 | |
| 2022-09-30 | $1.09B 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $660.30M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $739.99M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $597.46M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $578.52M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $547.81M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $509.22M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $420.42M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $324.51M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $310.57M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $302.29M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $300.75M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $207.26M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $203.11M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $195.24M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $185.24M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $178.21M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $172.07M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $180.33M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $184.97M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $179.28M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $165.63M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $169.99M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $75.78M 10-K · filed 2018-03-05 | |
| 2016-09-30 | $73.44M 10-Q/A · filed 2016-12-15 | $74.92M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $57.41M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $55.31M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $46.65M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $34.90M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $37.84M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $38.06M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $40.90M 10-K · filed 2016-03-03 | |
| 2014-09-30 | $13.55M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $17.45M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $21.10M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $28.75M 10-K · filed 2015-03-06 | |
| 2013-09-30 | $48.26M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $42.57M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $6.26M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $7.47M 10-K · filed 2014-03-07 | |
| 2012-09-30 | $4.74M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $4.10M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $4.52M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $4.59M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $5.03M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $5.50M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $7.48M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |